SCYNEXIS, Inc.

SCYX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 May 8, 2026 424B3
CORRESP May 6, 2026
UPLOAD May 6, 2026
S-3 May 1, 2026 S-3
DEF 14A Apr 30, 2026 DEF 14A
ARS Apr 30, 2026 ARS
DEFA14A Apr 30, 2026 DEFA14A
SCHEDULE 13G Apr 28, 2026
DEF 14A Apr 27, 2026 DEF 14A
PRE 14A Apr 20, 2026 PRE 14A
8-K Apr 20, 2026 8-K
PRE 14A Apr 17, 2026 PRE 14A
SCHEDULE 13G Apr 8, 2026
SCHEDULE 13G Apr 7, 2026
4 Apr 2, 2026 4
8-K Mar 31, 2026 8-K
8-K Mar 31, 2026 8-K
8-K Mar 31, 2026 8-K
10-K Mar 4, 2026 10-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
4 Feb 2, 2026 4
4 Feb 2, 2026 4
4 Feb 2, 2026 4
SCHEDULE 13G/A Jan 8, 2026
← Newer Page 2 of 30 · 742 filings Older →